OVERLAND PARK, Kan. , May 19, 2026 /PRNewswire/ -- Dechra is proud to announce the U.S. Food and Drug Administration's (FDA) approval of CosACTHen® (cosyntropin injection), the first and only ...
InnoPharma announced the launch of Cosyntropin Injection, the generic version of Amphastar’s Cortrosyn. Cortrosyn injection is a synthetic ACTH intended for use as a diagnostic agent in the screening ...
NATIONAL HARBOR, MD — Intravenous (IV) cosyntropin therapy in the treatment of postdural puncture headache shows efficacy that is similar to that of, but is slower to take effect than, the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results